These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pharmacologic reversal of hypotensive effect complicating antiarrhythmic therapy with bretylium. Woosley RL; Reele SB; Roden DM; Nies AS; Oates JA Clin Pharmacol Ther; 1982 Sep; 32(3):313-21. PubMed ID: 7105622 [No Abstract] [Full Text] [Related]
25. [Bretylium tosylate as an anti-arrhythmic drug]. Steffen V; Fiehring H Z Gesamte Inn Med; 1976 Nov; 31(22):913-9. PubMed ID: 798429 [TBL] [Abstract][Full Text] [Related]
26. Treatment of refractory ventricular arrhythmias. High dose parenteral and oral bretylium tosylate. Noneman JW; Batenhorst RL; Jones MR; Garrett ER; Foster TS Chest; 1982 Apr; 81(4):517-9. PubMed ID: 7067521 [No Abstract] [Full Text] [Related]
28. Bretylium tosylate in patients with acute myocardial infarction. Torresani J Am J Cardiol; 1984 Jul; 54(2):20A-25A. PubMed ID: 6464996 [TBL] [Abstract][Full Text] [Related]
29. Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias. Bacaner MB; Benditt DG Am J Cardiol; 1982 Oct; 50(4):728-34. PubMed ID: 6812406 [TBL] [Abstract][Full Text] [Related]
30. Effects of bretylium tosylate on the in vivo fibrillating canine ventricle. Breznock EM; Kagan K; Hibser NK Am J Vet Res; 1977 Jan; 38(1):89-94. PubMed ID: 835872 [TBL] [Abstract][Full Text] [Related]
31. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate. Kabell G J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895 [TBL] [Abstract][Full Text] [Related]
33. [Use of bretylium tosylate in ventricular fibrillation]. Arcidiacono R Clin Ter; 1978 Feb; 84(3):253-66. PubMed ID: 346298 [No Abstract] [Full Text] [Related]
34. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial. Haynes RE; Chinn TL; Copass MK; Cobb LA Am J Cardiol; 1981 Aug; 48(2):353-6. PubMed ID: 7023224 [TBL] [Abstract][Full Text] [Related]
35. [The effect of bretylium tosylate on ventricular arrhythmias in patients with acute myocardial infarction]. KochmaĆski M; Rdzanek H; Zochowski RJ Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):901-4. PubMed ID: 1341893 [TBL] [Abstract][Full Text] [Related]
36. Management of ventricular dysrhythmias in the prehospital and emergency department setting. Mayer NM Am J Cardiol; 1984 Jul; 54(2):34A-36A. PubMed ID: 6464998 [TBL] [Abstract][Full Text] [Related]
37. Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey. Puddu PE; Jouve R; Saadjian A; Torresani J J Pharmacol; 1986; 17(3):223-43. PubMed ID: 3795968 [TBL] [Abstract][Full Text] [Related]
38. Bretylium (Bretylol) for ventricular arrhythmias. Med Lett Drugs Ther; 1978 Dec; 20(24):105-6. PubMed ID: 713969 [No Abstract] [Full Text] [Related]
39. Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate. Bacaner MB Am J Cardiol; 1968 Apr; 21(4):530-43. PubMed ID: 5650734 [No Abstract] [Full Text] [Related]
40. Severe hypotension due to the use of bretylium for postcardiotomy ventricular arrhythmias. Kron IL; Nolan SP Ann Thorac Surg; 1983 Mar; 35(3):271-3. PubMed ID: 6600915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]